Things Get Worse For Gilead’s Magrolimab

Company Pauses Solid Tumor Study Enrollment

 
• By Alaric DeArment
  
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D